Pharmaeconomica SRL
0.3 FTEPharmaeconomica reported total assets of 152,818 € at the end of the 2026 financial year (annual accounts filed with the NBB on 30 Oct 2026), with 0.3 full-time equivalent.
The score of Pharmaeconomica shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2026
Change 2023 → 2026: Equity +175 % Total assets 0 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharmaeconomica's annual accounts
Filed annual accounts
- Year ended 30 Jun 2026filed on 30 Oct 2026
- Year ended 30 Jun 2025filed on 30 Sep 2025
- Year ended 30 Jun 2024filed on 09 Dec 2024
- Year ended 30 Jun 2023filed on 04 Dec 2023
Pharmaeconomica's financial analysis
- Solvency57.6%sector median: 58.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharmaeconomica
Pharmaeconomica's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0798.514.688
- VAT number
- BE0798514688
- Peppol
- Registered · 0208:0798514688 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 16 Feb 2023
- Registered office
- 8400 Ostend
- Size
- Micro · 0.3 FTE
- Latest accounts
- 2026 · filed on 30 Oct 2026
- Activity
- Business and other management consultancy activities (NACE 70200)
Pharmaeconomica (SRL) has been based in Ostend since 2023, active in: business and other management consultancy activities. For 2026, it reports a net profit of 41,094 € and equity of 87,986 €; its revenue is not published. With 0.3 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 57.6%, below the median of its sector (58.4%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Pharmaeconomica
Companies in the same business, of comparable size and area, outside its group.
- Loyersco Business and other management consultancy activities Namur · balance sheet 158,197 €
- Fuji Consult Business and other management consultancy activities Zaventem · balance sheet 148,200 €
- Inbit Business and other management consultancy activities Ninove · balance sheet 123,166 €
- VDR Consulting Business and other management consultancy activities Schilde · balance sheet 169,164 €
- MJSXpertise Business and other management consultancy activities Sint-Niklaas · balance sheet 105,505 €
- Laurent Jadot Consulting Business and other management consultancy activities Theux · balance sheet 160,405 €
- Jureal Business and other management consultancy activities Auderghem · balance sheet 178,613 €
- Auried Services Business and other management consultancy activities Waterloo · balance sheet 194,577 €
Frequently asked questions about Pharmaeconomica
What is the revenue of Pharmaeconomica?
Pharmaeconomica files its accounts in a format where revenue is optional: it is not published for 2026.
What is the VAT number of Pharmaeconomica?
In Belgium, the VAT number is the company number prefixed with BE: BE0798514688 for Pharmaeconomica, if the company is VAT-registered. Its company number (CBE) is 0798.514.688.
Where is the registered office of Pharmaeconomica?
According to the CBE register, the registered office of Pharmaeconomica is in 8400 Ostend.
What is the equity of Pharmaeconomica?
At the close of the 2026 financial year, the equity of Pharmaeconomica amounts to 87,986 €, a solvency of 57.6% of total assets.
How many people work at Pharmaeconomica?
0.3 full-time equivalents on average according to the 2026 social balance sheet.
Who manages Pharmaeconomica?
The register lists 1 active mandates at Pharmaeconomica. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharmaeconomica
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →